RAPS

Warfarin Patients Stand to Benefit from New FDA-Approved Drug Kcentra, Company Says

The US Food and Drug Administration (FDA) has approved Kcentra (prothrombin complex concentrate), a new biological treatment indicated for the urgent reversal of vitamin K antagonist (VKA), a class of ...
Hazleton Standard Speaker

VA hospital draws fire over access to ‘critical’ medication

Lack of 24-hour access to a potentially life-saving medication at the Department of Veterans Affairs Medical Center in Plains Twp. has raised concerns about the quality of care being offered to area ...
FierceBiotech

Harvard lands $50M for translational drug projects; FDA approves Kcentra to control warfarin-related bleeding;

> Harvard University has landed a $50 million gift to finance the Blavatnik Biomedical Accelerator, which will spur along translational medicine by finding promising therapeutic programs and putting ...
Monthly Prescribing Reference

Drug Approved for Urgent Warfarin Reversal

KCENTRA (prothrombin complex concentrate [human]) 500 Units Kcentra (CSL Behring) has been approved by the FDA for warfarin reversal during acute major bleeding. Kcentra does not require blood group ...
Newsday

Kcentra Approved to Stop Severe Bleeding in Heart Patients

Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug ...